immunotherapy, linomide, renal cell carcinoma
dx.doi.org/10.1016/S0959-8049(97)89027-2, hdl.handle.net/1765/67178
European Journal of Cancer
no subscription
Department of Medical Oncology

de Wit, R, Pawinsky, A, Stoter, G, van Oosterom, A.T, Fossa, S.D, Paridaens, R, … de Mulder, P.H.M. (1997). EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors. European Journal of Cancer, 33(3), 493–495. doi:10.1016/S0959-8049(97)89027-2